Citation: Yunyan Li, Zimin Cai, Zhicheng Wang, Sifeng Zhu, Wendian Liu, Cheng Wang. Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer[J]. Chinese Chemical Letters, ;2025, 36(4): 109942. doi: 10.1016/j.cclet.2024.109942 shu

Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer

Yunyan Li ^a ,
Zimin Cai ^a ,
Zhicheng Wang ^a ,
Sifeng Zhu ^a ,
Wendian Liu ^a ,
Cheng Wang ^{a, b, *,}

a.
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
b.
Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology, Qingdao 266237, China

cheng13980029671@163.com

Received Date: 20 February 2024
Revised Date: 24 April 2024
Accepted Date: 28 April 2024
Available Online: 29 April 2024

Figures(5)

Established evidence has unveiled two strategies for treating cancer: depleting tumor-associated macrophages (TAMs) and reprogramming M2-like TAMs into an antitumor M1 phenotype. Here, we designed novel pH-sensitive biomimetic hybrid nanovesicles (EDHPA) loaded with doxorubicin (DOX). DOX@EDHPA can specifically target TAMs by activating macrophage-derived exosomes (M1-Exos) and anisamide (AA) as cancer-specific targeting ligands. In vitro and in vivo studies demonstrated that DOX@EDHPA could efficiently be delivered to the tumor site and taken up by cells. Meanwhile, it synergistically enhanced immunogenic cell death (ICD) and induced a subsequent antigen-specific T cell immune response. The tumor inhibitory rate of the DOX@EDHPA group was 1.42 times that of the free DOX group. Further analysis showed that the excellent antitumor effects of DOX@EDHPA should ascribe to the homing effect of M1-Exos on macrophages and the repolarization to antitumor M1 TAMs, which induced the elevated secretion of pro-inflammatory factors. Therefore, the hybrid EDHPA targeting TAMs to reshape the tumor microenvironment constituted a novel immunochemotherapy strategy to inhibit tumor growth.
- Tumor-associated macrophages,
- M1-Exos,
- Hybrid nanovesicles,
- Immunogenic cell death,
- Immunochemotherapy
1. [1]
  S. Shen, H.J. Li, K.G. Chen, et al., Nano Lett. 17 (2017) 3822–3829. doi: 10.1021/acs.nanolett.7b01193
2. [2]
  Y. Chen, R. Xia, Y. Huang, et al., Nat. Commun. 7 (2016) 13443. doi: 10.1038/ncomms13443
3. [3]
  X. Duan, C. Chan, W. Han, et al., Nat. Commun. 10 (2019) 1899. doi: 10.1038/s41467-019-09221-x
4. [4]
  A.M. Cook, W.J. Lesterhuis, A.K. Nowak, R.A. Lake, Curr. Opin. Immunol. 39 (2016) 23–29. doi: 10.1016/j.coi.2015.12.003
5. [5]
  T.A.P. Driedonks, S.G. van der Grein, Y. Ariyurek, et al., Cell. Mol. Life Sci. 75 (2018) 3857–3875. doi: 10.1007/s00018-018-2842-8
6. [6]
  S. Quader, K. Kataoka, Mol. Ther. 25 (2017) 1501–1513. doi: 10.1016/j.ymthe.2017.04.026
7. [7]
  S. Kourembanas, Annu. Rev. Physiol. 77 (2015) 13–27. doi: 10.1146/annurev-physiol-021014-071641
8. [8]
  Y. Wu, Z. Zhang, Y. Wei, Z. Qian, X. Wei, Chin. Chem. Lett. 34 (2023) 108098. doi: 10.1016/j.cclet.2022.108098
9. [9]
  N.L. Syn, L.Z. Wang, E.K.H. Chow, C.T. Lim, B.C. Goh, Trends Biotechnol. 35 (2017) 665–676. doi: 10.1016/j.tibtech.2017.03.004
10. [10]
  J. Dai, Y. Su, S. Zhong, et al., Signal Transduct. Target Ther. 5 (2020) 145. doi: 10.1038/s41392-020-00261-0
11. [11]
  Y. Zhang, Y. Liu, H. Liu, W.H. Tang, Cell Biosci. 9 (2019) 19. doi: 10.1186/s13578-019-0282-2
12. [12]
  A. Mukherjee, B. Bisht, S. Dutta, M.K. Paul, Acta Pharmacol. Sin. 43 (2022) 2759–2776. doi: 10.1038/s41401-022-00902-w
13. [13]
  H. Zhang, K. Tang, Y. Zhang, et al., Cancer Immunol. Res. 3 (2015) 196–205. doi: 10.1158/2326-6066.CIR-14-0177
14. [14]
  F.O. Martinez, A. Sica, A. Mantovani, M. Locati, Front. Biosci. 13 (2008) 453–461. doi: 10.2741/2692
15. [15]
  M. Yang, J.Q. Chen, F. Su, et al., Mol. Cancer 10 (2011) 117.
16. [16]
  C.B. Anders, T.M.W. Lawton, H.L. Smith, et al., J. Leukoc. Biol. 111 (2022) 667–693. doi: 10.1002/jlb.6a1120-744r
17. [17]
  T. Yin, Q. Fan, F. Hu, et al., Nano Lett. 22 (2022) 6606–6614. doi: 10.1021/acs.nanolett.2c01863
18. [18]
  Y.W. Choo, M. Kang, H.Y. Kim, et al., ACS Nano 12 (2018) 8977–8993. doi: 10.1021/acsnano.8b02446
19. [19]
  J.A. Reales-Calderon, C. Vaz, L. Monteoliva, G. Molero, C. Gil, J. Proteome Res. 16 (2017) 87–105. doi: 10.1021/acs.jproteome.6b00605
20. [20]
  L. Cheng, X. Zhang, J. Tang, Q. Lv, J. Liu, Biomaterials 275 (2021) 120964. doi: 10.1016/j.biomaterials.2021.120964
21. [21]
  R. Majeti, M.P. Chao, A.A. Alizadeh, et al., Cell 138 (2009) 286–299. doi: 10.1016/j.cell.2009.05.045
22. [22]
  A. Macedo-Pereira, C. Martins, J. Lima, B. Sarmento, J. Control. Release 358 (2023) 98–115.
23. [23]
  Q. Lv, L. Cheng, Y. Lu, et al., Adv. Sci. 7 (2020) 2000515. doi: 10.1002/advs.202000515
24. [24]
  M.S. Kim, M.J. Haney, Y. Zhao, et al., Nanomedicine 14 (2018) 195–204.
25. [25]
  K.M. Kanninen, N. Bister, J. Koistinaho, T. Malm, Biochim. Biophys. Acta 1862 (2016) 403–410.
26. [26]
  S.M. van Dommelen, P. Vader, S. Lakhal, et al., J. Control. Release 161 (2012) 635–644.
27. [27]
  J. Gao, S. Wang, Z. Wang, Biomaterials 135 (2017) 62–73.
28. [28]
  M. Piffoux, A.K.A. Silva, C. Wilhelm, F. Gazeau, D. Tareste, ACS Nano 12 (2018) 6830–6842. doi: 10.1021/acsnano.8b02053
29. [29]
  W.J. Goh, S. Zou, C.K. Lee, et al., Biomacromolecules 19 (2018) 22–30. doi: 10.1021/acs.biomac.7b01176
30. [30]
  Y. Lin, J. Wu, W. Gu, et al., Adv. Sci. 5 (2018) 1700611.
31. [31]
  M. Hu, J. Zhang, L. Kong, et al., ACS Nano 15 (2021) 3123–3138. doi: 10.1021/acsnano.0c09681
32. [32]
  A. Dasargyri, C.D. Kümin, J.C. Leroux, Adv. Mater. 29 (2016) 1603451.
33. [33]
  J. Cho, Y.S. Lee, S.H. Kim, J.K. Ko, C.W. Kim, Cancer Lett. 275 (2009) 256–265. doi: 10.3346/jkms.2009.24.2.256
34. [34]
  S. Rayamajhi, T.D.T. Nguyen, R. Marasini, S. Aryal, Acta Biomater. 94 (2019) 482–494.
35. [35]
  D. Kalyane, N. Raval, R. Maheshwari, et al., Mater. Sci. Eng. C Mater. Biol. Appl. 98 (2019) 1252–1276.
1. [1]
  Xiaopeng Han , Jiayin Li , Fei Li , Zhongyue Yuan , Hao Li , Lei Yang , Yan-Ming Xia , Chao Teng , Chao Qin , Lifang Yin . ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade. Chinese Chemical Letters, 2026, 37(2): 111335-. doi: 10.1016/j.cclet.2025.111335
2. [2]
  Kun-Heng Li , Hong-Yang Zhao , Dan-Dan Wang , Ming-Hui Qi , Zi-Jian Xu , Jia-Mi Li , Zhi-Li Zhang , Shi-Wen Huang . Mitochondria-targeted nano-AIEgens as a powerful inducer for evoking immunogenic cell death. Chinese Chemical Letters, 2024, 35(5): 108882-. doi: 10.1016/j.cclet.2023.108882
3. [3]
  Yanjun Cai , Yong Jiang , Yu Chen , Erzhuo Cheng , Yuan Gu , Yuwei Li , Qianqian Liu , Jian Zhang , Jifang Liu , Shisong Han , Bin Yang . Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy. Chinese Chemical Letters, 2025, 36(5): 110437-. doi: 10.1016/j.cclet.2024.110437
4. [4]
  Xin Li , Fei Xiong , Xudong Cao , Wei Liu , Haobo Chen , Jiayu He , Weina Zhang , Longguang Tang , Wei Huang , Xikuang Yao . CD44-targeting and ZIF-8 gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death. Chinese Chemical Letters, 2026, 37(1): 110970-. doi: 10.1016/j.cclet.2025.110970
5. [5]
  Jiayi Sun , Luyao Huang , Wenfeng Jia , Yitong Liu , Li Xiang , Xing Yang , Fan Tong , Xiaobo Wang , Huile Gao , Yi Zhang . Nanodelivery strategies modulating tumor stromal cells for reverting the immunosuppressive tumor microenvironment. Chinese Chemical Letters, 2026, 37(4): 112036-. doi: 10.1016/j.cclet.2025.112036
6. [6]
  Xueying Shi , Xiaoxuan Zhou , Bing Xiao , Hongxia Xu , Wei Zhang , Hongjie Hu , Shiqun Shao , Zhuxian Zhou , Youqing Shen , Xiaodan Xu , Jianbin Tang . A β-lapachone-loaded iron-polyphenol nanocomplex enhances chemodynamic therapy through cascade amplification of ROS in tumor. Chinese Chemical Letters, 2025, 36(5): 110178-. doi: 10.1016/j.cclet.2024.110178
7. [7]
  Muhammad Nafees , Muhammad Hanif , Piaoping Yang . Metallodrugs: From mere cytotoxic agents to immune modulators and checkpoint inhibitors. Chinese Chemical Letters, 2026, 37(4): 111013-. doi: 10.1016/j.cclet.2025.111013
8. [8]
  Rongrong Zheng , Zuxiao Chen , Qiuyuan Li , Ni Yang , Wenjun Zhang , Chuyu Huang , Linping Zhao , Xin Chen , Hong Cheng , Shiying Li . Endoplasmic reticulum targeting photodynamic oxidizer to boost anti-tumor immunity by intensifying immunogenic cell death in conjunction with IDO1 inhibition. Chinese Chemical Letters, 2025, 36(12): 110865-. doi: 10.1016/j.cclet.2025.110865
9. [9]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
10. [10]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
11. [11]
  Qiuyue Lu , Min Shan , Jiaqi Yang , Zhongren Xu , Yueyue Lei , Wukun Liu . A dinuclear gold(I) complex with bis(N-heterocyclic carbene) ligands potentiated immune responses against liver cancer via ROS-driven endoplasmic reticulum stress and ferroptosis. Chinese Chemical Letters, 2025, 36(12): 110940-. doi: 10.1016/j.cclet.2025.110940
12. [12]
  Tengfei Zhang , Chen Han , Chiyuan Wei , Xing Wang , Zhihui Jia , Hong-Min Meng , Zhaohui Li . Ratiometric fluorescence probe using semiconducting polymer nanoparticles and carbon dots for predicting anti-cancer efficiency. Chinese Chemical Letters, 2026, 37(3): 111566-. doi: 10.1016/j.cclet.2025.111566
13. [13]
  Dou Zhang , Xinyi Cai , Yimin Li , Yong Liu , Long Qiu , Zhenying Diao , Xuyi Liu , Yuta Nishina , Yajuan Zou , Jianbo Sun , Shujing Liang , Daxiang Cui , Ting Yin . Nanozyme with dual enzyme activity mediating cascade catalytic therapy synergize multiple functions for antitumor therapy. Chinese Chemical Letters, 2026, 37(3): 111569-. doi: 10.1016/j.cclet.2025.111569
14. [14]
  Xinlu Zhang , Yongxin Liu , Huan Li , Shutong Chen , Guocheng Wang , Xu Zhang , Chen Cao , Xiaoyuan Chen , Sheng Wang . A hypoxia-activated copper ion nanoexchanger for cancer immunotherapy by in situ precise production of immunogenic cell death inducer. Chinese Chemical Letters, 2026, 37(3): 111404-. doi: 10.1016/j.cclet.2025.111404
15. [15]
  Hanyong Wang , Weijia Zhang , Chenlu Huang , Xinyu Yang , Qingyu Yu , Hai Wang , Wen Li , Linhua Zhang , Dunwan Zhu . Personalized tumor vaccines based on carrier-free double-adjuvant nanoparticles and tumor-associated antigens for enhancing immune responses. Chinese Chemical Letters, 2025, 36(7): 111092-. doi: 10.1016/j.cclet.2025.111092
16. [16]
  Huige Zhang , Wei Chen , Yuyan Huang , Mingfang Wu , Hongli Chen , Cuiling Ren , Xiaoyan Liu , Haixia Zhang . Construction of template-free amplification system coupled with capillary electrophoresis for the simultaneous detection of three tumor-associated DNA repair enzymes. Chinese Chemical Letters, 2025, 36(9): 110721-. doi: 10.1016/j.cclet.2024.110721
17. [17]
  Zixuan Chen , Yafeng Wu , Zhaoyan Tian , Zhaohan Wang , Weiwei Liu , Songqin Liu . A reproducible hybrid membrane for in situ analysis of cell secretions with a wide size range. Chinese Chemical Letters, 2025, 36(12): 110917-. doi: 10.1016/j.cclet.2025.110917
18. [18]
  Zhi-Yuan Yue , Hua-Kai Li , Na Wang , Shan-Shan Liu , Le-Ping Miao , Heng-Yun Ye , Chao Shi . Dehydration-triggered structural phase transition-associated ferroelectricity in a hybrid perovskite-type crystal. Chinese Chemical Letters, 2024, 35(10): 109355-. doi: 10.1016/j.cclet.2023.109355
19. [19]
  Peng Gao , Yuanyuan Chen , Qianlin He , Xue Liu , Echuan Tan , Zhiqiang Yu , Hui Wang . Highly efficient adoptive cell therapy of metastatic triple negative breast cancer with bioactive covalent organic framework-engineered macrophages. Chinese Chemical Letters, 2025, 36(8): 110585-. doi: 10.1016/j.cclet.2024.110585
20. [20]
  Jiahao Liu , Peng Liu , Junhong Duan , Qiongxuan Xie , Jie Feng , Hongpei Tan , Ze Mi , Ying Li , Yunjie Liao , Pengfei Rong , Wenhu Zhou , Xiang Gao . Macrophages-mediated tumor accumulation and deep penetration of bismuth/manganese biomineralized nanoparticles for enhanced radiotherapy. Chinese Chemical Letters, 2024, 35(12): 109632-. doi: 10.1016/j.cclet.2024.109632

Get Citation

PDF

XML

Metrics

PDF Downloads(4)
Abstract views(1904)
HTML views(98)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142